Differentiation in the Amsterdam methadone dispensing circuit: Determinants of methadone dosage and site of methadone prescription

Addiction

Volumn 93, Issue 1, 1998, Pages 61-72

  Langendam, Miranda W ^a   Van Haastrecht, Harry J A ^a   Van Brussel, Giel H A ^a   Reurs, Hans ^a   Van Den Hoek, Anneke A R ^a   Coutinho, Roel A ^a   Van Ameijden, Erik J C ^a  

^a MUNICIPAL HEALTH SERVICE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE;

ADULT; AGE; ARTICLE; ETHNIC GROUP; FEMALE; GENERAL PRACTITIONER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; NETHERLANDS; OPIATE ADDICTION; OUTPATIENT DEPARTMENT; POLICE; PRESCRIPTION; PRISON; PROSTITUTION; REGISTER;

EID: 0031963477     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1360-0443.1998.931617.x     Document Type: Article

References (26)

1. GOSSOP, M. & GRANT, M. (1991) A six country survey of the content and structure of heroin treatment programmes using methadone, British Journal of Addiction, 86, 1151-1160.
2. BUNING, E. C. (1994) Methadone in Europe, International Journal of Drug Policy, 5, 221-225.
3. FARRELL, M., NEELEMAN, J., GOSSOP, M. et al. (1995) Methadone provision in the European Union, International Journal of Drug Policy, 6, 168-172.
4. BUNING, E. C., COUTINHO, R. A., VAN BRUSSEL, G. H. A., VAN SANTEN, G. W. & VAN ZADELHOFF, A. W. (1986) Preventing AIDS in drug addicts in Amsterdam (letter), Lancet, ii, 1435.
5. BUNING, E. C., VAN BRUSSEL, G. H. A. & VAN SANTEN, G. W. (1990) The practical business of treatment-12: the 'methadone by bus' project in Amsterdam, British Journal of Addiction, 85, 1247-1250.
6. BUSTER, M. C. A. (1994) Afdeling Sociale en Psychiatrische Epidemiologie GGZ. Methadonverstrekking in Amsterdam in 1993. Jaarverslag van de Centrale Methadon Registratie [Department of Social and Psychiatric Epidemiology, Municipal Health Service Amsterdam. Methadone dispensing in Amsterdam in 1993. Annual report of the Central Methadone Register].
7. BUNING, E. C. (1990) De GG&GD en het drug-probleem in cijfers, deel IV [The Municipal Health Service and the drug problem in figures, part IV] (Amsterdam, Municipal Health Service).
8. PLOMP, H. N., VAN DER HEK, H. & ADÈR, H. J. (1996) The Amsterdam Methadone Dispensing Circuit: genesis and effectiveness of a public health model for local drug policy, Addiction, 91, 711-721.
9. PLOMP, H. N. & REIJNEVELD, S. A. (1991) Methadonverstrekking aan druggebruikers in Amsterdam [Methadone dispensing in Amsterdam] (Amsterdam, VU-press).
10. REIJNEVELD, S. A. (1992) Ambulante methadon-verstrekking in Amsterdam: een gedifferentieerd systeem? [Ambulatory dispension of methadone in Amsterdam: a differentiated system?] Tijdschrift voor Sociale Gezondheidszorg, 70, 592-598.
11. VAN DEN HOEK, J. A. R., COUTINHO, R. A., VAN HAASTRECHT, H. J. A., VAN ZADELHOFF, A. W. & GOUDSMIT, J. (1988) Prevalence and risk factors of HIV infections among drug users and drug-using prostitutes in Amsterdam, AIDS, 2, 55-60.
12. VAN DEN HOEK, J. A. R., VAN HAASTRECHT, H. J. A. & COUTINHO, R. A. (1989) Risk reduction among intravenous drug users in Amsterdam under the influence of AIDS, American Journal of Public Health, 79, 1355-1357.
13. VAN HAASTRECHT, H. J. A., VAN DEN HOEK, J. A. R., BARDOUX, C., LEENTVAAR-KUIJPERS, A. & COUTINHO, R. A. (1991) The course of the HIV epidemic among intravenous drug users in Amsterdam, The Netherlands, American Journal of Public Health, 81, 59-62.
14. LIANG, K. Y. & ZEGER, S. L. (1986) Longitudinal data analysis using generalized linear models, Biometrika, 73, 13-22.
15. ZEGER, S. L. & LIANG, K. (1986) Longitudinal data analysis for discrete and continuous outcomes, Biometrics, 42, 121-130.
16. BALL, J. C., LANGE, W. R., MYERS, C. P. & FRIEDMAN, S. R. (1988) Reducing the risk of AIDS through methadone maintenance treatment, Journal of Health & Social Behaviour, 29, 214-226.
17. DOLE, V. P. (1988) Implications of methadone maintenance for theories of narcotic addiction, Journal of the American Medical Association, 260, 3025-3029.
18. YANCOVITZ, S. R., DES JARLAIS, D. C., PESKOE, N. et al. (1991) A randomized trial of an interim methadone maintenance clinic, American Journal of Public Health, 81, 1185-1191.
19. HARTGERS, C., VAN DEN HOEK, J. A. R., KRIJNEN, P. & COUTINHO, R. A. (1992) HIV prevalence and risk behaviour among injecting drug users who participate in "low threshold" methadone programs in Amsterdam, American Journal of Public Health, 82, 547-551.
20. JENKINS, J. A., KEENAN, R. M. & HENNINGFIELD, J. E. (1994) Pharmacokinetics and pharmacodynamics of smoked heroin, Journal of Analytic Toxicology, 18, 317-330.
21. MO, B. P. & WAY, E. L. (1966) An assessment of inhalation as a mode of administration of heroin by addicts, Journal of Pharmacologic Experimental Therapy, 154, 142-151.
22. VAN BRUSSEL, G. H. A., VAN DER WOUDE, D. H. & VAN LIESHOUT, S. J. M. (1994) Werkt het Amsterdamse sociaal-medische drugshulpbeleid? Jaarbericht van de Drugsafdeling GG&GD waarin opgenomen de jaarcijfers 1993 [The social-medical care policy for drug users in Amsterdam: does it work? Annual report of Drug Department of the Municipal Health Service Amsterdam 1993].
23. BORCHERDING, S. M., BACIEWICZ, A. M. & SELF, T. H. (1992) An update on rifampin drug interactions II, Archives of Internal Medicine, 152, 711-716.
24. VAN AMEIJDEN, E. J. C., VAN DEN HOEK, J. A. R., VAN HAASTRECHT, H. J. A. & COUTINHO, R. A. (1992) The harm reduction approach and risk factors for human immunodeficiency virus (HIV) seroconversion in injecting drug users, Amsterdam (see comments), American Journal of Epidemiology, 136, 236-243.
25. VAN AMEIJDEN, E. J. C., VAN DEN HOEK, J. A. R. & COUTINHO, R. A. (1994) Injecting risk behaviour among drug users in Amsterdam, 1986 to 1992, and its relationship to AIDS prevention programs, American Journal of Public Health, 84, 275-281.
26. VAN HAASTRECHT, H. J. A., VAN AMEIJDEN, E. J. C., VAN DEN HOEK, J. A. R., MIENTJES, G. H. C., BAX, J. S. & COUTINHO, R. A. (1996) Predictors of mortality in the Amsterdam cohort of human immunodeficiency virus (HIV)-positive and HIV-negative drug users, American Journal of Epidemiology, 143, 380-391.